Literature DB >> 18614999

HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells.

Paul E Rosenstiel1, Tina Gruosso, Audrey M Letourneau, Justin J Chan, Amanda LeBlanc, Mohammad Husain, Vesna Najfeld, Vicente Planelles, Vivette D D'Agati, Mary E Klotman, Paul E Klotman.   

Abstract

Transgenic mouse models of HIV-associated nephropathy (HIVAN) show that expression of HIV-1 genes in kidney cells produces collapsing focal segmental glomerulosclerosis and microcystic tubular disease typical of the human disease. HIV-1 vpr plays an important role in the glomerulosclerosis of HIVAN, especially when it is associated with nef expression in podocytes. Further, Vpr is reported to exacerbate tubular pathology. Here we determined effects of vpr expression on renal tubular epithelial cell function by transducing them with a pseudotyped lentivirus vector carrying HIV-1 vpr and control genes. Vpr expression in the cultured cells impaired cytokinesis causing cell enlargement and multinucleation. This profound in vitro phenotype caused us to reexamine the HIVAN mouse model and human HIVAN biopsies to see if similar changes occur in vivo. Both showed abundant hypertrophic tubule cells similar to the in vitro finding that represents a previously unappreciated aspect of the human disease. Additionally, multinucleated tubular cells were identified in the murine HIVAN model and increased chromosome number was detected in tubular cells of human HIVAN biopsies. Our study provides evidence of a new clinical phenotype in HIVAN that may result from the ability of Vpr to impair cytokinesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614999      PMCID: PMC4039560          DOI: 10.1038/ki.2008.303

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  42 in total

1.  Is the prevalence of HIV-associated nephropathy decreasing?

Authors:  T S Ahuja; M Borucki; M Funtanilla; V Shahinian; M Hollander; S Rajaraman
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

2.  HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney.

Authors:  M J Ryan; G Johnson; J Kirk; S M Fuerstenberg; R A Zager; B Torok-Storb
Journal:  Kidney Int       Date:  1994-01       Impact factor: 10.612

3.  Renal epithelium is a previously unrecognized site of HIV-1 infection.

Authors:  Leslie A Bruggeman; Michael D Ross; Nozomu Tanji; Andrea Cara; Steven Dikman; Ronald E Gordon; Godfrey C Burns; Vivette D D'Agati; Jonathan A Winston; Mary E Klotman; Paul E Klotman
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

4.  Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

Authors:  V Shahinian; S Rajaraman; M Borucki; J Grady; W M Hollander; T S Ahuja
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

5.  Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.

Authors:  Erik S Zimmerman; Michael P Sherman; Jana L Blackett; Jason A Neidleman; Christophe Kreis; Pamela Mundt; Samuel A Williams; Maria Warmerdam; James Kahn; Frederick M Hecht; Robert M Grant; Carlos M C de Noronha; Andrew S Weyrich; Warner C Greene; Vicente Planelles
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy.

Authors:  Michael J Ross; Scott Martinka; Vivette D D'Agati; Leslie A Bruggeman
Journal:  J Am Soc Nephrol       Date:  2005-06-23       Impact factor: 10.121

7.  Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.

Authors:  L Barisoni; M Mokrzycki; L Sablay; M Nagata; H Yamase; P Mundel
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

8.  Multiple centrosome formation induced by the expression of Vpr gene of human immunodeficiency virus.

Authors:  Y Minemoto; M Shimura; Y Ishizaka; Y Masamune; K Yamashita
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

9.  Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

Authors:  S R Bartz; M E Rogel; M Emerman
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study.

Authors:  V D'Agati; J I Suh; L Carbone; J T Cheng; G Appel
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

View more
  24 in total

1.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

2.  Glomerular MYH9 expression is reduced by HIV-1.

Authors:  Thomas Hays; Vivette D D'Agati; Jonathan A Garellek; Tjani Warren; Marc E Trubin; Deborah P Hyink; John Cijiang He; Paul E Klotman
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

3.  Renal epithelial cells produce and spread HIV-1 via T-cell contact.

Authors:  Maria Blasi; Bala Balakumaran; Ping Chen; Donatella R M Negri; Andrea Cara; Benjamin K Chen; Mary E Klotman
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

4.  Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells.

Authors:  Ping Chen; Benjamin K Chen; Arevik Mosoian; Thomas Hays; Michael J Ross; Paul E Klotman; Mary E Klotman
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

Review 5.  HIV-associated nephropathy: pathogenesis.

Authors:  Raj K Medapalli; John C He; Paul E Klotman
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

6.  Polyploidy and Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes in Renal Tubule Epithelial Cells.

Authors:  Emily H Payne; Dhivya Ramalingam; Donald T Fox; Mary E Klotman
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

7.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

8.  Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy.

Authors:  Leyi Gu; Yan Dai; Jin Xu; Sandeep Mallipattu; Lewis Kaufman; Paul E Klotman; John C He; Peter Y Chuang
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

9.  Inhibition of apoptosis signal-regulating kinase 1 mitigates the pathogenesis of human immunodeficiency virus-associated nephropathy.

Authors:  Anqun Chen; Jin Xu; Han Lai; Vivette D D'Agati; Tian-Jun Guan; Shawn Badal; John Liles; John C He; Kyung Lee
Journal:  Nephrol Dial Transplant       Date:  2021-02-20       Impact factor: 5.992

10.  HIV-1 Vpr activates the DNA damage response in renal tubule epithelial cells.

Authors:  Paul E Rosenstiel; Justin Chan; Alexander Snyder; Vicente Planelles; Vivette D D'Agati; Paul E Klotman; Mary E Klotman
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.